2016
DOI: 10.18632/oncotarget.13652
|View full text |Cite
|
Sign up to set email alerts
|

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway

Abstract: Cortactin (CTTN) is overexpressed in various tumors, including head and neck squamous cell carcinoma and colorectal cancer (CRC), and can serve as a biomarker of cancer metastasis. We observed that CTTN promotes cancer cell proliferation in vitro and increases CRC tumor xenograft growth in vivo. CTTN expression increases EGFR protein levels and enhances the activation of the MAPK signaling pathway. CTTN expression also inhibits the ubiquitin-mediated degradation of EGFR by suppressing the coupling of c-Cbl wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 48 publications
(44 reference statements)
1
20
2
Order By: Relevance
“…36 Cortactin has been associated with tumor spreading and aggressive phenotypes, and suggested as a biomarker to predict metastasis. 37 In marked contrast to these data, cortactin expression was not found to correlate with nodal metastasis in our cohort of cSCC patients and showed no impact on survival. Nevertheless, our findings are in good agreement with those reported by Sato et al in Head and neck squamous cell carcinoma.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…36 Cortactin has been associated with tumor spreading and aggressive phenotypes, and suggested as a biomarker to predict metastasis. 37 In marked contrast to these data, cortactin expression was not found to correlate with nodal metastasis in our cohort of cSCC patients and showed no impact on survival. Nevertheless, our findings are in good agreement with those reported by Sato et al in Head and neck squamous cell carcinoma.…”
Section: Discussioncontrasting
confidence: 99%
“…Cortactin overexpression has been found in multiple cancers, including head and neck squamous cell carcinoma, oral squamous cell carcinoma lung squamous cell carcinoma, gliosarcoma, breast cancer, colorectal cancer, and melanoma . Cortactin has been associated with tumor spreading and aggressive phenotypes, and suggested as a biomarker to predict metastasis . In marked contrast to these data, cortactin expression was not found to correlate with nodal metastasis in our cohort of cSCC patients and showed no impact on survival.…”
Section: Discussioncontrasting
confidence: 94%
“…CRC is ranked as the sixth most prevalent cancer and the fifth most common factor for cancer-related deaths with the higher incidence in males and urban regions in China (17). Apart from environmental and acquired risk factors in the tumorigenic effect, a variety of genetic alterations and uncontrolable regulation of signaling pathways can also lead to the disorder of cell cycle or unlimited proliferation of the intestinal mucosal epithelial cells to seriously affect their normal growth regulation, eventually resulting in the transformation of normal colonic epithelium to CRC (18,19). For example, activation of Notch signaling pathway can influence cellular activities, such as cell proliferation, anti-apoptosis, or cellular migration and invasion in CRC, which is of great value for the clinical development of target therapeutic drugs (20).…”
Section: Discussionmentioning
confidence: 99%
“…Cortactin (CTTN) and Clusterin (CLU) are well established regulators of cancer metastasis and drug resistance [4547] as well as are associated with the gene ontology biological process - negative regulation of apoptotic signaling pathway (GO:2001234). While CLU has a chaperone role, CTTN works as an actin cytoskeleton regulator downstream to Src kinase, another protein dis-regulated in different cancers [48].…”
Section: Resultsmentioning
confidence: 99%